Adenosine Receptors and Parkinson's Disease

1st Edition

Editors: Hiroshi Kase Peter Richardson Peter Jenner
Hardcover ISBN: 9780124004054
eBook ISBN: 9780080525952
Imprint: Academic Press
Published Date: 15th October 1999
Page Count: 275
215.00 + applicable tax
17200.00 + applicable tax
130.00 + applicable tax
165.00 + applicable tax
195.00 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Description

This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease.

Key Features

Key Features

  • Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease
  • Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease
  • Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum
  • Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints

Readership

Neuroscientists, neurologists, pharmacologists, biochemists, and geneticists, especially all workers in the basal ganglia, purine, and Parkinson's fields.

Table of Contents

H. Kase, Introductory Remarks: Adenosine A2A Receptor Antagonists: A Novel Approach to the Treatment of Parkinson's Disease.

S.J. Augood, P.C. Emsom, and D.G. Standaert, Localisation of Adenosine Receptors in Brain and Periphery.

J. Shimada and F. Suzuki, Medicinal Chemistry of Adenosine Receptors in Brain and Periphery.

A. Karasawa, Overview of the Physiology and Pharmacology of Adenosine in the Peripheral System.

H. Nonaka and M. Ichimura, Biochemical Characterizatoin of Adenosine Agonists and Antagonists.

A. Mori and T. Shindou, Physiology of Adenosine Receptors in the Striatum: Regulation of Striatal Projection Neurons.

P. Richardson and M. Kurokawa, The Regulation of Neurotransmitter Release in Basal Ganglia by Adenosine Receptor Agonists and Antagonists in Vitro and in Vivo.

A. Dixon and P. Richardson, Control of Gene Expression in the Basal Ganglia Induced by Adenosine Receptors.

S. Aoyama, J.-H. Baik, H. Kase, and E. Borrelli, Knockout Mice in the Study of Dopaminergic Diseases.

S. Shiozaki, S. Ichikawa, J. Nakamura, and Y. Kuwana, Effects of Adenosine Receptors Experimental Models of Cognition and Motor Behaviour.

T. Kanda and P. Jenner, Actions of Adenosine Antagonists in a Primate Model of Parkinson's Disease.

A. Tahar, R. Grondin, L. Gregoire, A. Mori, H. Kase, and P.J. Bedard, Selective Adenosine A2A Receptor Antagonism as an Alternative Therapy for Parkinson's Disease: A Study in Nonhuman Primates.

M. Nomoto, Neurobiology of Adenosine Receptors: Adenosine and its Metabolites in Movement Disorders.

Details

No. of pages:
275
Language:
English
Copyright:
© Academic Press 2000
Published:
Imprint:
Academic Press
eBook ISBN:
9780080525952
Hardcover ISBN:
9780124004054

About the Editor

Hiroshi Kase

Affiliations and Expertise

Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan

Peter Richardson

Affiliations and Expertise

University of Cambridge, U.K.

Peter Jenner

Affiliations and Expertise

King's College, London, U.K. Head of Pharmacology and Therapeutics Division